Single-source·Aug 19, 2026·1 sources analyzed
Senate Health Panel Chairman Questions F.D.A. Nominee
Senator Bill Cassidy has expressed concerns regarding Dr. Heidi Overton's nomination to the Food and Drug Administration. Cassidy cited Overton's involvement in a recent executive order on vaccines as a significant issue. (sources: nytimes)
Image: nytimes
Modern Action Briefing
Senator Bill Cassidy raised reservations about Dr. Heidi Overton's nomination to the F.D.A., describing her recent role in a vaccine-related executive order as potentially disqualifying.
- Senator Bill Cassidy chairs the Senate Health Panel.
- Dr. Heidi Overton was nominated for a position at the F.D.A.
- Cassidy's comments suggest a lack of support for Overton's nomination.
Why it matters
The outcome of Overton's nomination could impact the leadership and direction of the F.D.A.
Sources used · 1 source